{"id":95025,"date":"2019-08-20T10:43:01","date_gmt":"2019-08-20T17:43:01","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/08\/juvenescence-secures-100m-for-rejuvenative-therapies"},"modified":"2019-08-20T10:43:01","modified_gmt":"2019-08-20T17:43:01","slug":"juvenescence-secures-100m-for-rejuvenative-therapies","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/08\/juvenescence-secures-100m-for-rejuvenative-therapies","title":{"rendered":"Juvenescence Secures $100M for Rejuvenative Therapies"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/juvenescence-secures-100m-for-rejuvenative-therapies2.jpg\"><\/a><\/p>\n<p>It seems that billionaire biotech investor Jim Mellon is the flavor of the month as he continues the drive to create a rejuvenation biotech industry. Jim and his colleagues at <a href=\"https:\/\/www.juvenescence.ltd\/\" target=\"_blank\" rel=\"noopener\">Juvenescence<\/a> have announced that <a href=\"https:\/\/juvenescence.ltd\/juvenescence-closes-100-million-series-b-round-plans-follow-on-and-incremental-investments-in-longevity-drug-development\/\" target=\"_blank\" rel=\"noopener\">they have secured another $100M<\/a> for the company, and it will be used to invest and support the growth of promising biotech companies working in this field.<\/p>\n<p>Juvenescence has a varied investment portfolio of companies that range in potential usefulness, depending on your point of view, and they mostly favor the more traditional small molecule drug approach. There are a few companies that are of particular interest.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It seems that billionaire biotech investor Jim Mellon is the flavor of the month as he continues the drive to create a rejuvenation biotech industry. Jim and his colleagues at Juvenescence have announced that they have secured another $100M for the company, and it will be used to invest and support the growth of promising [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-95025","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/95025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=95025"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/95025\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=95025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=95025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=95025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}